Longeveron Announces Successful Completion of Phase 2b Clinical Study of Lomecel-B Infusion to Treat Aging Frailty

    NEXT STORY
    Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
    PREV STORY
    Coastline’s Acquired Brain Injury (ABI) Program is partnering with Brain Strategies & Technology (BEST) and Global Brain Injury Awareness (GBIA) to Celebrate Brain Injury Awareness Month
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CB2 Insights Announces $3,000,000 Private Placement Led by Merida Capital

    author_avatar
    NASDAQ Market News

    Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017

    RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

    author_avatar
    NASDAQ Market News

    TRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA

    author_avatar
    NASDAQ Market News